BRIEF published on 02/02/2026 at 17:15, 1 month 7 days ago Piramal Pharma Solutions Unveils Tablet-in-Capsule Technology Drug Delivery Piramal Pharma Tablet-in-Capsule Patient Centricity Customized Dosing
BRIEF published on 02/02/2026 at 17:15, 1 month 7 days ago Piramal Pharma Solutions dévoile une technologie de comprimés en capsule. Administration De Médicaments Centré Sur Le Patient Piramal Pharma Comprimé En Capsule Dosage Personnalisé
PRESS RELEASE published on 02/02/2026 at 17:10, 1 month 7 days ago Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities Piramal Pharma Solutions successfully develops tablet-in-capsule drug delivery system, offering flexible dosing options for oral therapies. Enhancing patient-centric solutions Drug Delivery System Patient-centric Piramal Pharma Solutions Tablet-in-Capsule Flexible Dosing Options
BRIEF published on 12/15/2025 at 07:10, 2 months 26 days ago Piramal Pharma Solutions Achieves High Net Promoter Score Operational Excellence Net Promoter Score Customer Loyalty Piramal Pharma Competitive Positioning
BRIEF published on 12/15/2025 at 07:10, 2 months 26 days ago Piramal Pharma Solutions obtient un score de recommandation client élevé Excellence Opérationnelle Fidélité Client Piramal Pharma Score Net De Promoteur Positionnement Concurrentiel
PRESS RELEASE published on 12/15/2025 at 07:05, 2 months 26 days ago Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score Piramal Pharma Solutions achieves impressive Net Promoter Score (NPS) of 55, surpassing industry averages, reflecting commitment to excellence and stakeholder centricity Operational Excellence Net Promoter Score Piramal Pharma Solutions NPS Stakeholder Centricity
BRIEF published on 11/26/2025 at 20:30, 3 months 13 days ago Piramal Pharma Solutions Ensures Compliance with Nitrosamine Regulations Regulatory Standards Piramal Pharma Solutions Nitrosamine Compliance Pharmaceutical Safety Testing Capabilities
BRIEF published on 11/26/2025 at 20:30, 3 months 13 days ago Piramal Pharma Solutions garantit la conformité aux réglementations sur les nitrosamines Normes Réglementaires Sécurité Pharmaceutique Conformité Aux Nitrosamines Capacités De Test Solutions Pharmaceutiques Piramal
PRESS RELEASE published on 11/26/2025 at 20:25, 3 months 13 days ago Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities Piramal Pharma Solutions achieves regulatory compliance for nitrosamine impurities, ensuring safety & adherence to global guidelines, enhancing capabilities & operational excellence Regulatory Compliance Operational Excellence Patient Safety Piramal Pharma Solutions Nitrosamine Impurities
BRIEF published on 11/19/2025 at 09:00, 3 months 20 days ago Piramal Pharma's Grangemouth Facility Secures Updated MHRA GMP Certifications ADC Development GMP Certification MHRA Approval Piramal Pharma Grangemouth Facility
Published on 03/10/2026 at 00:30, 6 hours 41 minutes ago FutureGen Industries Announces Shares for Debt Settlement
Published on 03/09/2026 at 21:50, 9 hours 21 minutes ago Jaguar Mining Receives Approval for Resumption of Operations at Its MTL Complex (Turmalina Mine), Brazil
Published on 03/09/2026 at 21:10, 10 hours 1 minute ago Zentek Provides PDAC 2026 Update - Government and First Nations Engagement
Published on 03/09/2026 at 17:15, 13 hours 56 minutes ago Alta Copper Corp. and Nascent Exploration Pty Ltd Announce Completion of Plan of Arrangement
Published on 03/09/2026 at 14:00, 17 hours 11 minutes ago urban-gro, Inc. Regains Full Nasdaq Compliance Following Balance Sheet and Governance Improvements
Published on 03/10/2026 at 07:00, 11 minutes ago Komax Group significantly reduces costs and achieves positive operating result
Published on 03/10/2026 at 07:00, 11 minutes ago Lindt & Sprüngli achieves double-digit organic growth and higher profitability
Published on 03/10/2026 at 07:00, 11 minutes ago Partners Group's operating profit (EBITDA) increases 19% to CHF 1.61 billion, also supported by stronger performance fees; proposed dividend of CHF 46.00 per share
Published on 03/10/2026 at 07:00, 11 minutes ago Axelera® AI Adds Kudelski Labs’ Security IP to Europa® Chip to Enable Secure, High-Performance Edge AI
Published on 03/10/2026 at 07:00, 11 minutes ago Press release: Leonteq announces board nominations and publishes agenda for the annual general meeting 2026
Published on 03/09/2026 at 18:43, 12 hours 28 minutes ago Reporting on share buyback transactions carried out between March 2 and March 6, 2026
Published on 03/09/2026 at 18:43, 12 hours 28 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 2 au 6 mars 2026
Published on 03/09/2026 at 18:21, 12 hours 50 minutes ago TERACT - EN REPONSE A L’OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS ET LES BSAR B DE LA SOCIÉTÉ TERACT
Published on 03/09/2026 at 18:00, 13 hours 11 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 03/09/2026 at 18:00, 13 hours 11 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
